Fig. 3From: Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosisAdjusted changes in lung function before and after treatment. a Serial adjusted changes in FVC, DLco, and TLC before treatment. b Serial adjusted changes in FVC, DLco, and TLC after treatment. Each dot and error bar represent the mean and 95% confidence interval. *p < 0.05 (compared with baseline values). Total, total patients; FVC, forced vital capacity; DLco, diffusing capacity of the lung for carbon monoxide; TLC, total lung capacityBack to article page